` 1786 (SciVision Biotech Inc) vs Taiwan Weighted Index Comparison - Alpha Spread

1786
vs
Taiwan Weighted Index

Over the past 12 months, has outperformed Taiwan Weighted Index, delivering a return of 48% compared to the Taiwan Weighted Index's 32% growth.

Stocks Performance
1786 vs Taiwan Weighted Index

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1786 vs Taiwan Weighted Index

Loading
1786
Taiwan Weighted Index
Difference

Performance By Year
1786 vs Taiwan Weighted Index

Loading
1786
Taiwan Weighted Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
SciVision Biotech Inc vs Peers

Taiwan Weighted Index
1786
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

SciVision Biotech Inc
Glance View

Market Cap
8B TWD
Industry
Health Care

SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. The company is headquartered in Kaohsiung, Kaohsiung. The company went IPO on 2010-12-29. The firm primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The firm is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The firm operates its business in the Americas, Europe, Asia, Middle East and Africa.

Intrinsic Value
151.59 TWD
Undervaluation 25%
Intrinsic Value
Price
Back to Top